Category: Trial Briefs
Early Kidney Disease Diagnosis Rates Stagnant
Early kidney disease diagnosis rates remain stagnant despite increased screening, highlighting challenges in healthcare detection.
Valbenazine Improves Quality of Life in Tardive Dyskinesia
New study finds valbenazine significantly improves quality of life for adults with tardive dyskinesia.
Dual Therapy Shifts SMA Treatment Landscape
Discover how dual therapy is reshaping spinal muscular atrophy treatment as experts debate combining treatments...
Neurology and Headache Societies Release New Migraine Guideline
The American Academy of Neurology and American Headache Society released an updated migraine prevention guideline...
Combined Risk Factors Linked to Late Parkinson Disease
Study reveals combined risk factors significantly increase late-onset Parkinson disease risk, with multiple exposures showing...
Sarkey Highlights Oveporexton Impact on Type 1 Narcolepsy
FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn...
Architects of the hunt design deadly strategies
Architects of the hunt design deadly strategies in media regulation. Sign the open letter calling...
Patients left at risk by poor communication standards
Australia’s new health safety standards may overlook critical communication risks for deaf patients, leaving them...
Bail laws hurt public health and safety
Bail laws hurt public health and safety, reform is urgently needed to address moral and...
AI Threatens Traditional Medical Education
AI threatens traditional medical education with 81% of doctors using AI in practice and education,...